A Noninferiority RCT Comparing Operative vs Nonoperative Treatment for ER-stress Positive Weber-B Unimalleolar Fractures
A Prospective Randomized Non-inferiority Trial to Compare Operative Versus Non-operative Treatment for ER-stress Positive Weber-B Unimalleolar Fractures
1 other identifier
interventional
126
1 country
1
Brief Summary
Current gold standard treatment for unstable (those found unstable in external rotation (ER) stress testing Weber B-type, Lauge-Hansen supination-external rotation type IV) ankle fractures is open reduction and internal fixation (ORIF) with semitubular plates and screws. However, there is some preliminary evidence to suggest that these type of fibula fractures can be managed non-operatively with comparable functional outcome. The aim of this randomized, non-inferiority trial is to assess whether non-operative treatment (cast immobilisation) yields a non-inferior functional outcome compared to surgery with no excess harms (primarily, fracture and wound healing problems and infection).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 26, 2012
CompletedFirst Posted
Study publicly available on registry
January 1, 2013
CompletedStudy Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 7, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedSeptember 14, 2023
September 1, 2023
8.5 years
December 26, 2012
September 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Olerud-Molander Outcome Score (OMAS)
OMAS; scale from 0 to 100, higher scores indicating better outcomes and fewer symptoms. validated, condition-specific, patient-reported measure of ankle fracture symptoms.
2 years
Secondary Outcomes (5)
The Foot and Ankle Outcome Score (FAOS)
2 years
RAND 36 Health Item Survey (RAND-36)
2 years
a 100 mm Visual Analogue Scale for function and pain (VAS)
2 years
Fracture healing
2 years
Ankle joint movement
2 years
Other Outcomes (1)
Talocrural joint congruence
At two, six and 12 weeks, and at 2 years
Study Arms (2)
Non-operative
EXPERIMENTALNon-operative treatment with six weeks in a below-the-knee cast. Partial weight-bearing (15 to 20 kilograms) for the first four weeks and then weight-bearing as tolerated for the remaining two weeks.
Surgery
ACTIVE COMPARATOROpen reduction and internal fixation with 1/3 semitubular plate and screws. Post-operatively, surgically treated ankles are placed in a below-the-knee cast for six weeks. They are advised to carry out partial weight-bearing (15 to 20 kilograms) for the first four weeks and then weight-bear as tolerated for the remaining two weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Weber B unimalleolar ankle fracture
- Age: 16 years or older
- Voluntary
- Operated within 7 days of the trauma
- Walking without aid before accident
You may not qualify if:
- Peripheral neuropathy
- Pilon fracture
- Bilateral ankle fracture
- Simultaneous crural fracture
- Pathological fracture
- Active infection around the ankle
- A previous ankle fracture or significant medial ligament trauma
- Lives outside our hospital district or a foreigner
- Co-operation is insufficient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
OYS, Oulu university hospital, Department of orthopedic and traumatology
Oulu, North Ostrobothnia, 90100, Finland
Related Publications (1)
Kortekangas T, Lehtola R, Leskela HV, Taimela S, Ohtonen P, Savola O, Jarvinen TLN, Pakarinen H. Cast immobilisation versus surgery for unstable lateral malleolus fractures (SUPER-FIN): randomised non-inferiority clinical trial. BMJ. 2026 Jan 14;392:e085295. doi: 10.1136/bmj-2025-085295.
PMID: 41534905DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Harri J Pakarinen, MD, PhD
Oulu University Hospital
- PRINCIPAL INVESTIGATOR
Tero HJ Kortekangas, MD, PhD
Oulu University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Interpretation of data is blinded to treatment group allocation. More precisely, the interpretation of data is carried out without knowledge of the actual treatment given to the particular group, rather labelling groups as "Group 1" and "Group 2". Only then the randomization code is broken, correct data interpretation is chosen, and the draft of the manuscript is finalised.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Orthopedic surgeon, MD, PhD
Study Record Dates
First Submitted
December 26, 2012
First Posted
January 1, 2013
Study Start
January 1, 2013
Primary Completion
July 7, 2021
Study Completion
April 1, 2024
Last Updated
September 14, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
Trial data are not publicly available owing to data privacy, but access to the anonymised dataset can be obtained from the corresponding author on reasonable request.